Skip to main content

Following FDA Alert, J&J Issues First Time Recall of Baby Powder

Following FDA Alert, J&J Issues First Time Recall of Baby Powder

Following FDA Alert, J&J Issues First Time Recall of Baby Powder

Introduction

On October 18, Johnson & Johnson, the U.S. healthcare conglomerate facing thousands of lawsuits over its talc-containing products, announced a voluntary recall of a single batch of its baby powder after receiving an alert from the US Food and Drug Administration (FDA) that it tested positive for asbestos, a known cancer-causing substance.

As per the statement released by the healthcare company, the FDA found sub-trace levels of chrysotile asbestos contamination at concentrations not exceeding 0.00002% in a single bottle purchased from an online retailer. The recall applies to lot #22318RB resulting in recall of 33,000 bottles of talcum powder. J&J said it has started an investigation and is reviewing manufacturing records and collecting data on the distribution of the lot to determine where the product was shipped.

Time and again J&J has defended its talcum-powder calling it safe, stating that decades of studies have shown the products to be asbestos-free and that they do not cause cancer. However, the FDA said it stands by the quality of its testing and results and recommended that consumers stop using the product if it comes from the affected lot.

Nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits are consolidated under multidistrict litigation MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation. Lawsuits are also pending in a coordinated California proceeding under Judicial Council Coordinated Proceeding No. 4877.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.